Justification of a prevention policy of perinatal disease by group B streptococci (GBS) . Recommendations
Andreu, A.; de la Rosa, M.; Cabero, L.
Enfermedades Infecciosas y Microbiologia Clinica 17(3): 138-140
1999
ISSN/ISBN: 0213-005X PMID: 10217850 Document Number: 506135
Document emailed within 1 workday
Related Documents
Håkansson, S. 1984: Infections caused by group B streptococci--a perinatal problem Lakartidningen 81(23): 2351-2353Kind, C.; Duc, G. 1996: Prenatal and perinatal infections--problems for the practicing pediatrician: group B streptococci, varicella, toxoplasmosis Schweizerische Medizinische Wochenschrift 126(7): 264-276
Bergogne-Berezin, E.; Slim, A. 1976: The diagnosis of a group of Streptococci. 1 - Comparative study of various techniques for the extraction of the polyoside antigen from Streptococci Annales de Biologie Clinique 34(5): 329-333
Jensen, N.E.; Andersen, B.L.; Buhl, G. 1979: Streptococcus group B. a study of the occurrence of Group B streptococci in venereological and gynecological patients and in a control group Ugeskrift for Laeger 141(15): 992-994
1989: AIDS prevention and education. Recommendations of the Work Group Journal of adolescent health care: official publication of the Society for Adolescent Medicine 10(3 Suppl): 45S-47S
Jorm, L.R.; Love, D.N.; Bailey, G.D.; McKay, G.M.; Briscoe, D.A. 1994: Genetic structure of populations of beta-haemolytic Lancefield group C streptococci from horses and their association with disease Research in Veterinary Science 57(3): 292-299
1984: Prevention of bacterial endocarditis. Recommendations of the Swiss Work Group for the Prevention of Endocarditis Schweizerische Medizinische Wochenschrift 114(37): 1246-1252
Gohlke, H.; Kübler, W.; Mathes, P.; Meinertz, T.; Schuler, G.; Gysan, D.B.; Sauer, G. 2001: Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group Zeitschrift für Kardiologie 90(2): 148-149
1987: Synopsis of the 3d Public Health Council recommendation concerning AIDS: guidelines for group screening and recommendations for prevention Nederlands Tijdschrift Voor Geneeskunde 131(2): 53-55
Uzochukwu, B.; Onwujekwe, O.; Mbachu, C.; Okwuosa, C.; Etiaba, E.; Nyström, M.E.; Gilson, L. 2016: The challenge of bridging the gap between researchers and policy makers: experiences of a Health Policy Research Group in engaging policy makers to support evidence informed policy making in Nigeria Globalization and Health 12(1): 67
Wang, Y.F.; Sun, M.X.; Xue, H.; Zhao, W.H.; Yang, X.G.; Zhu, X.Y.; Zhao, L.; Yang, Y.X. 2019: Understanding the China Blue Paper on Obesity Prevention and Control and policy implications and recommendations for obesity prevention and control in China Zhonghua Yu Fang Yi Xue Za Zhi 53(9): 875-884
McGetrick, J.Ann.; Kongats, K.; Raine, K.D.; Voyer, C.; Nykiforuk, C.I.J. 2019: Healthy Public Policy Options to Promote Physical Activity for Chronic Disease Prevention: Understanding Canadian Policy Influencer and General Public Preferences Journal of Physical Activity and Health 16(7): 565-574
Cunniff, H.; Bump, C.M. 1976: Extrarespiratory non-group A, non-group D isolates of streptococci American Journal of Medical Technology 42(6): 195-200
Gerbi, B.J.; Antolak, J.A.; Deibel, F.Christopher.; Followill, D.S.; Herman, M.G.; Higgins, P.D.; Huq, M.Saiful.; Mihailidis, D.N.; Yorke, E.D.; Hogstrom, K.R.; Khan, F.M. 2009: Recommendations for clinical electron beam dosimetry: supplement to the recommendations of Task Group 25 Medical Physics 36(7): 3239-3279
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450
Pinon, F. 1983: Remote future of infants with perinatal hemolytic disease due to fetomaternal blood group incompatibility Soins. Gynecologie Obstetrique Puericulture Pediatrie 1983(27-28): 29-31
1994: Proceedings and recommendations of the Expert Working Group on Emerging Infectious Disease Issues. Lac Tremblant Declaration. December 1993 Canada Communicable Disease Report 20 Suppl. 2: Iii
Owens, D.K. 2017: Aspirin for the Prevention of Cardiovascular Disease and Colorectal Cancer: New Recommendations from the USPSTF American Family Physician 95(4): 222-223
Grosse, S.D.; Boyle, C.A.; Cordero, Jé.F. 2005: Newborn screening for cystic fibrosis: recommendations from the Centers for Disease Control and Prevention American Family Physician 71(8): 1482 1487